CRTAC1 can be used as a biomarker for osteoarthritis severity and progression via plasma proteomics analysis (Szilagyi et al., 2023), demonstrating the role of CRTAC1 and related diverse pathways in chondrocyte pathologies. The gene discussed is CRTAC1; the disease is osteoarthritis.